Mesa Laboratories Future Growth

Future criteria checks 3/6

Mesa Laboratories is forecast to grow earnings and revenue by 54.2% and 4.6% per annum respectively while EPS is expected to grow by 53.8% per annum.

Key information

54.2%

Earnings growth rate

53.84%

EPS growth rate

Life Sciences earnings growth	13.8%
Revenue growth rate	4.6%
Future return on equity	n/a
Analyst coverage	Low
Last updated	07 Aug 2025

Recent future growth updates

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08

Recent updates

Mesa Laboratories (NASDAQ:MLAB) Is Paying Out A Dividend Of $0.16

Aug 20

It's Down 27% But Mesa Laboratories, Inc. (NASDAQ:MLAB) Could Be Riskier Than It Looks

Jul 20

Mesa Laboratories (NASDAQ:MLAB) Is Due To Pay A Dividend Of $0.16

Jul 15

Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Intrinsic Value Is Potentially 32% Above Its Share Price

Jul 07

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jan 07

Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle

Dec 19

Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

Nov 20

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Oct 17

A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Jul 29

Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

May 03

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mar 15

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Dec 05

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Sep 28

Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Aug 09

We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Jun 28

Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

May 31

A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Apr 12

Earnings and Revenue Growth Forecasts

NasdaqGS:MLAB - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2028	276	14	N/A	N/A	1
3/31/2027	262	7	36	43	3
3/31/2026	249	9	29	34	3
6/30/2025	242	-1	33	38	N/A
3/31/2025	241	-2	42	47	N/A
12/31/2024	238	-249	43	47	N/A
9/30/2024	228	-246	36	40	N/A
6/30/2024	224	-250	42	45	N/A
3/31/2024	216	-254	42	44	N/A
12/31/2023	213	1	41	44	N/A
9/30/2023	214	-1	36	40	N/A
6/30/2023	219	2	36	41	N/A
3/31/2023	219	1	23	28	N/A
12/31/2022	222	-1	20	25	N/A
9/30/2022	223	-4	28	33	N/A
6/30/2022	200	-2	23	27	N/A
3/31/2022	184	2	35	39	N/A
12/31/2021	163	8	39	43	N/A
9/30/2021	143	5	36	38	N/A
6/30/2021	139	4	42	44	N/A
3/31/2021	134	3	35	37	N/A
12/31/2020	130	-2	31	32	N/A
9/30/2020	128	-2	31	32	N/A
6/30/2020	121	-2	27	29	N/A
3/31/2020	118	2	25	27	N/A
12/31/2019	110	5	27	28	N/A
9/30/2019	105	10	27	28	N/A
6/30/2019	104	8	24	25	N/A
3/31/2019	103	7	N/A	31	N/A
12/31/2018	104	10	N/A	30	N/A
9/30/2018	101	-2	N/A	29	N/A
6/30/2018	99	0	N/A	30	N/A
3/31/2018	96	-3	N/A	26	N/A
12/31/2017	94	-4	N/A	17	N/A
9/30/2017	94	11	N/A	14	N/A
6/30/2017	95	11	N/A	7	N/A
3/31/2017	94	11	N/A	17	N/A
12/31/2016	94	12	N/A	14	N/A
9/30/2016	90	11	N/A	9	N/A
6/30/2016	88	10	N/A	18	N/A
3/31/2016	85	11	N/A	17	N/A
12/31/2015	78	9	N/A	15	N/A
9/30/2015	76	9	N/A	16	N/A
6/30/2015	73	10	N/A	13	N/A
3/31/2015	71	10	N/A	11	N/A
12/31/2014	68	11	N/A	9	N/A
9/30/2014	64	10	N/A	11	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MLAB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.1%).

Earnings vs Market: MLAB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MLAB is expected to become profitable in the next 3 years.

Revenue vs Market: MLAB's revenue (4.6% per year) is forecast to grow slower than the US market (9.7% per year).

High Growth Revenue: MLAB's revenue (4.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MLAB's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/09/22 16:39
End of Day Share Price	2025/09/22 00:00
Earnings	2025/06/30
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mesa Laboratories, Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Vijay Kumar	Evercore ISI
Paul Knight	Janney Montgomery Scott LLC
Tycho Peterson	Jefferies LLC

Mesa Laboratories Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Price target decreased by 13% to US$105

Price target increased by 13% to US$150

Price target increased by 10% to US$130

Consensus EPS estimates upgraded to US$0.055 loss

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Price target decreased by 17% to US$115

Recent updates

Upcoming dividend of US$0.16 per share

Mesa Laboratories (NASDAQ:MLAB) Is Paying Out A Dividend Of $0.16

New minor risk - Share price stability

Price target decreased by 13% to US$105

First quarter 2026 earnings: EPS exceeds analyst expectations while revenues lag behind

It's Down 27% But Mesa Laboratories, Inc. (NASDAQ:MLAB) Could Be Riskier Than It Looks

Mesa Laboratories (NASDAQ:MLAB) Is Due To Pay A Dividend Of $0.16

Mesa Laboratories, Inc., Annual General Meeting, Aug 22, 2025

Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Intrinsic Value Is Potentially 32% Above Its Share Price

Fourth quarter dividend of US$0.16 announced

Mesa Laboratories: Strong Order Growth And Positive Valuation Outlook

Mesa Labs Declares Quarterly Dividend, Payable on September 15, 2025

Mesa Laboratories, Inc. to Report Q1, 2026 Results on Aug 05, 2025

Insufficient new directors

Mesa Laboratories, Inc.(NasdaqGS:MLAB) dropped from Russell 2000 Value Index

CEO, President & Director notifies of intention to sell stock

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Full year 2025 earnings: EPS misses analyst expectations

Upcoming dividend of US$0.16 per share

Third quarter dividend of US$0.16 announced

Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on June 16, 2025

Investors Interested In Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Revenues

CEO, President & Director notifies of intention to sell stock

At US$135, Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Worth Looking At Closely?

Upcoming dividend of US$0.16 per share

Price target increased by 13% to US$150

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Mesa Laboratories, Inc. to Report Q3, 2025 Results on Feb 04, 2025

Second quarter dividend of US$0.16 announced

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 22% Below Their Intrinsic Value Estimate

Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on March 17, 2025

Mesa Laboratories: GKE Acquisition New Crown Jewel, Still Doesn't Move The Needle

Upcoming dividend of US$0.16 per share

Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

Second quarter 2025 earnings: EPS exceeds analyst expectations

CEO, President & Director recently sold US$572k worth of stock

CEO, President & Director notifies of intention to sell stock

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

First quarter dividend of US$0.16 announced

Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on December 16, 2024

Insider notifies of intention to sell stock

Price target increased by 10% to US$130

A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Fourth quarter dividend of US$0.16 announced

Mesa Laboratories, Inc., Annual General Meeting, Aug 30, 2024

Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on September 16, 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Mesa Laboratories, Inc. Reports Impairment of Goodwill and Long-Lived Assets for the Fourth Quarter Ended March 31, 2024

Upcoming dividend of US$0.16 per share

Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

Third quarter dividend of US$0.16 announced

Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on June 14, 2024

Mesa Laboratories, Inc. to Report Q4, 2024 Results on May 24, 2024

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Consensus EPS estimates upgraded to US$0.055 loss

Upcoming dividend of US$0.16 per share

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Mesa Laboratories, Inc. Appoints Mark Capone to Its Board of Directors

Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on March 15, 2024

Insider notifies of intention to sell stock

Mesa Laboratories, Inc. to Report Q3, 2024 Results on Feb 05, 2024

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Upcoming dividend of US$0.16 per share at 0.7% yield

Price target decreased by 17% to US$115

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Mesa Laboratories, Inc. (NasdaqGS:MLAB) entered into a definitive agreement to acquire Beijing GKE Science & Technology Co. LTD for €5 million.

Mesa Laboratories, Inc. (NasdaqGS:MLAB) acquired Sterilization indicators business of GKE-GmbH and SAL GmbH from Gke-GmbH for €80 million.